p53 Promotes Cell Survival due to the Reversibility of Its Cell-Cycle Checkpoints

Abstract

Although p53 status has been suggested as a clinical predictor of chemotherapeutic efficacy, studies to date have not always supported this. This study demonstrates that p53 is still an important determinant of cell fate in response to chemotherapy, under the appropriate treatment conditions.